Most Popular White Papers
Content provided in partnership with
Health Care Industry
Industry: Email Alert RSS FeedBarr Laboratories
Drug Store News, August 18, 2003 by James Frederick
Barr Laboratories settled its patent litigation late last month with Ortho-McNeil Pharmaceutical and, as a result, will be permitted to introduce a generic version of the oral contraceptive Ortho Tri-Cyclen no later than Dec. 29.
Ortho Tri-Cyclen is an oral contraceptive that includes three different tablet combinations of norgestimate and ethinyl estradiol and is indicated for the prevention of pregnancy. The product, available in 28-tablet packaging, had annual sales of about $713 million for the 12 months ended May.
COPYRIGHT 2003 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
Find Research Guides for:
Find Featured Titles for: Autos
Most Popular Articles in Health
- Fuel your workout: exercisers who eat before they work out have more energy ...
- Soothe a dry, itchy scalp: 5 easy expert solutions
- Cocktails and calories: Beer, wine and liquor calories can really add up. ...
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- The, six best supplements you've never heard of: these secret weapons can ...
- More »